What Is the Highest Dose of Olanzapine?

The highest FDA-approved dose of olanzapine is 20 mg per day for adults. This ceiling applies to both schizophrenia and bipolar I disorder, whether olanzapine is used alone or alongside other medications. The FDA label states explicitly that olanzapine “is not indicated for use in doses above 20 mg/day” and that safety above this level has not been evaluated in clinical trials.

That said, some prescribers do go higher in specific situations, and the reasons the 20 mg ceiling exists tell you a lot about how the drug works in your brain.

Why 20 mg Is the Official Limit

Olanzapine works partly by blocking dopamine receptors in the brain. Brain imaging studies using PET scans have mapped exactly how much receptor blockade you get at each dose level. At 5 mg per day, roughly 55% of dopamine receptors are occupied. At 10 mg, it jumps to 73%. At 15 mg, 75%. At 20 mg, 76%. The curve flattens quickly, meaning each additional milligram above 10 or 15 mg buys you very little extra receptor coverage.

Push past 20 mg and occupancy climbs into the 80% range (83% at 30 mg, 88% at 40 mg in one patient studied). That sounds like more therapeutic effect, but crossing the 80% threshold is where problems start. Patients in PET studies who exceeded 80% dopamine receptor occupancy developed movement-related side effects like stiffness and restlessness, along with elevated levels of the hormone prolactin. These are the same side effects that older antipsychotics are known for, and staying below 80% occupancy is a big part of what makes olanzapine better tolerated at standard doses.

In the same imaging study, two patients who weren’t responding well had their doses raised to 30 and 40 mg per day. Neither showed further clinical improvement despite the higher receptor occupancy. More drug didn’t translate into more benefit, but it did bring more side effects.

Off-Label Use Above 20 mg

Despite the official ceiling, doses between 20 and 45 mg per day are sometimes used off-label for treatment-resistant schizophrenia, particularly when clozapine (the standard medication for treatment-resistant cases) isn’t an option due to side effects or monitoring requirements. Meta-analyses examining dose-response patterns have found increasing efficacy at doses beyond the typical 5 to 20 mg range in treatment-resistant populations, which is why some clinicians try it.

This is a trade-off, not a free lunch. Higher doses carry greater risk of weight gain, metabolic changes, sedation, and the movement-related side effects described above. The decision to exceed 20 mg is made on a case-by-case basis when the severity of symptoms justifies the added risk.

Long-Acting Injectable Formulation

Olanzapine also comes as a long-acting injection (Zyprexa Relprevv) given every two to four weeks. The highest evaluated dose is 405 mg every four weeks or 300 mg every two weeks. The effective range runs from 150 mg to 300 mg every two weeks, or 405 mg every four weeks. This formulation is only administered in certified healthcare facilities because it carries a risk of a post-injection reaction that can cause heavy sedation.

Why Some People Need More Than Others

Your body’s metabolism plays a significant role in how much olanzapine actually reaches your brain at any given dose. Smoking is the single biggest variable. Cigarette smoke activates a liver enzyme that breaks down olanzapine faster, meaning smokers clear the drug roughly 30% more efficiently than nonsmokers. In practical terms, a smoker taking 20 mg per day may have blood levels equivalent to a nonsmoker taking only about 14 mg.

This matters for dose adjustments in both directions. If you smoke and then quit, your olanzapine levels can rise significantly without any change in your prescription, potentially increasing side effects. Conversely, a smoker who isn’t responding at a standard dose may genuinely have subtherapeutic blood levels, which is one reason clinicians sometimes push doses higher for these patients.

What Happens in Overdose

In cases where people have taken well above the prescribed maximum, the pattern is fairly consistent. At doses under 200 mg taken at once, symptoms typically appear within one to two hours and include rapid heart rate, agitation, confusion, dry mouth, fever, and heavy sedation. Heart rhythm has generally remained stable in reported cases, though the heart rate itself rises.

At very high overdose levels, profound sedation sets in quickly, sometimes alongside symptoms that resemble a dangerous drug reaction called neuroleptic malignant syndrome: high fever, muscle rigidity, agitation alternating with mutism, and elevated markers of muscle breakdown in blood tests. These cases require emergency medical attention, but the majority of olanzapine overdoses, even at high amounts, are survivable with supportive care.